Shares of Cadila Healthcare touched 52-week high of Rs 555.55, rose nearly 3 percent intraday Monday on the back of final approval from USFDA to market Nystatin Topical Powder USP, 100000 units per ...

New Delhi, Jun 10 (PTI) Zydus Group firm Cadila Healthcare today said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical powder used for treating skin ...

Nystatin 100000Units/g; in talc. Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. Nystatin acts by binding to sterols ...

New Delhi: Zydus Group firm Cadila Healthcare on Saturday said its subsidiary Nesher Pharmaceuticals has received nod from the USFDA to market Nystatin topical powder used for treating skin infections ...

Nystatin cream is an antifungal, antibiotic treatment for fungal infections of the skin. It can help resolve yeast infections but is only suitable for use on the skin. Nystatin cream is a topical ...

BACKGROUND: Invasive fungal infection is associated with significant morbidity and mortality in preterm infants. Studies have suggested that colonization with Candida species is an important risk ...

* Says co's wholly owned unit Epic Pharma, LLC received FDA approval for its Nystatin Topical Powder from U.S Food and Drug Administration ...

Zydus Group firm Cadila Healthcare today said its subsidiary Nesher Pharmaceuticals has received a nod from the USFDA to market Nystatin topical powder used for treating skin infections in the US ...